Technical Analysis for SAVA - Cassava Sciences, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 3.83 | -10.94% | -0.47 |
SAVA closed down 10.94 percent on Tuesday, November 26, 2024, on 7.5 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing Low | Bearish | 0.00% | |
Volume Surge | Other | 0.00% | |
Calm After Storm | Range Contraction | 0.00% | |
NR7 | Range Contraction | 0.00% | |
NR7-2 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.00% | |
New 52 Week Low | Weakness | 0.00% | |
Stochastic Reached Oversold | Weakness | 0.00% | |
Wide Bands | Range Expansion | 0.00% |
Alert | Time |
---|---|
Possible NR7 | about 7 hours ago |
Fell Below Previous Day's Low | about 9 hours ago |
New 52 Week Low | about 9 hours ago |
Down 10% | about 10 hours ago |
60 Minute Opening Range Breakdown | about 10 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/07/2024
Cassava Sciences, Inc. develops drugs for nervous system disorders in the United States. It engages in developing FENROCK, a proprietary abuse-deterrent transdermal pain patch for pain relief; PTI-125, a small molecule drug candidate to treat Alzheimer's disease; and PTI-125DX, a blood-based diagnostic/biomarker to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was founded in 1998 and is based in Austin, Texas.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Pain Neuroscience Alzheimer's Disease Mental Health Biomarkers Psychiatric Diagnosis Psychiatry Nervous System Disorders Abnormal Psychology Transdermal
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Pain Neuroscience Alzheimer's Disease Mental Health Biomarkers Psychiatric Diagnosis Psychiatry Nervous System Disorders Abnormal Psychology Transdermal
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 42.2 |
52 Week Low | 3.65 |
Average Volume | 4,387,317 |
200-Day Moving Average | 22.75 |
50-Day Moving Average | 26.53 |
20-Day Moving Average | 24.35 |
10-Day Moving Average | 22.70 |
Average True Range | 3.91 |
RSI (14) | 23.08 |
ADX | 19.5 |
+DI | 16.95 |
-DI | 45.65 |
Chandelier Exit (Long, 3 ATRs) | 22.26 |
Chandelier Exit (Short, 3 ATRs) | 15.37 |
Upper Bollinger Bands | 38.24 |
Lower Bollinger Band | 10.47 |
Percent B (%b) | -0.24 |
BandWidth | 114.01 |
MACD Line | -3.10 |
MACD Signal Line | -0.92 |
MACD Histogram | -2.1784 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 4.85 | ||||
Resistance 3 (R3) | 4.90 | 4.62 | 4.68 | ||
Resistance 2 (R2) | 4.62 | 4.36 | 4.59 | 4.62 | |
Resistance 1 (R1) | 4.22 | 4.19 | 4.08 | 4.17 | 4.56 |
Pivot Point | 3.94 | 3.94 | 3.86 | 3.91 | 3.94 |
Support 1 (S1) | 3.54 | 3.68 | 3.40 | 3.49 | 3.09 |
Support 2 (S2) | 3.26 | 3.51 | 3.23 | 3.03 | |
Support 3 (S3) | 2.86 | 3.26 | 2.98 | ||
Support 4 (S4) | 2.81 |